| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Previous 10% Owner | 10% Owner
1 company
Lineage Cell Therapeutics, Inc. serves as a Previous 10% Owner at LCTX. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $6.6M at current prices.
The biggest single holding is LCTX (~$6.6M) as Previous 10% Owner. The recent filings there lean toward selling, a net 8,633,090 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2020 | LCTX Lineage Cell Therapeutics, Inc. | Previous 10% Owner | Sell | 2,383,090 | $2.16 | $5,137,942.04 | -28.3% | |
| Sep 11, 2019 | LCTX Lineage Cell Therapeutics, Inc. | 10% Owner | Sell | 4,000,000 | $1.66 | $6,640,000.00 | -32.2% | |
| Jul 5, 2019 | LCTX Lineage Cell Therapeutics, Inc. | 10% Owner | Sell | 2,250,000 | $2.00 | $4,500,000.00 | -15.3% |